N Aarts1, R Noordam1, A Hofman2, H Tiemeier3, B H Stricker4, L E Visser5. 1. Department of Internal Medicine, Erasmus Medical Center, P.O. Box 2040, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. 2. Department of Epidemiology, Erasmus Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Netherlands Consortium of Healthy Ageing, P.O. Box 2040, Rotterdam, The Netherlands. 3. Department of Epidemiology, Erasmus Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Department of Psychiatry, Erasmus Medical Center, P.O. Box 2040, Rotterdam, The Netherlands; Department of Child and Adolescent Psychiatry, Erasmus Medical Center, P.O. Box 2040, Rotterdam, The Netherlands. 4. Department of Epidemiology, Erasmus Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Netherlands Consortium of Healthy Ageing, P.O. Box 2040, Rotterdam, The Netherlands; Inspectorate of Health Care, P.O. Box 2040, the Hague, The Netherlands. Electronic address: b.stricker@erasmusmc.nl. 5. Department of Epidemiology, Erasmus Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Apotheek Haagse Ziekenhuizen - HAGA, P.O. Box 2040, The Hague, The Netherlands.
Abstract
BACKGROUND: In middle-aged and older patients in whom antidepressant use increased in last decades, patterns of use might be of concern The objective of this study was to investigate the patterns of prevalence, incidence and duration of antidepressant use in an ageing population. METHODS: All participants (aged>45 years) from the population-based Rotterdam Study were followed from January 1st 1991 until death, loss to follow-up, or end of the study period (December 31st 2011). Antidepressant drug dispensing, based on pharmacy records, were subdivided into Tricyclic Antidepressants (TCAs), Selective Serotonin Reuptake Inhibitors (SSRIs) and other antidepressants. One-year prevalence, 5-year incidence and duration of antidepressant use were calculated. RESULTS: Yearly prevalence of antidepressant use increased from 3.9% in 1991 to 8.3% of the population in 2011. The increase in SSRI use was 5.8-fold, whereas use of other antidepressants doubled and TCA use remained stable over time. Incidence of all antidepressants decreased from 23.9 to 14.2 per 1000 person-years between 1992 and 2011. The duration of a first treatment episode increased over time. CONCLUSION: Despite the prevalence of antidepressant use increased over time, incidence did not, which is most likely explained by a longer treatment duration and recurrent episodes.
BACKGROUND: In middle-aged and older patients in whom antidepressant use increased in last decades, patterns of use might be of concern The objective of this study was to investigate the patterns of prevalence, incidence and duration of antidepressant use in an ageing population. METHODS: All participants (aged>45 years) from the population-based Rotterdam Study were followed from January 1st 1991 until death, loss to follow-up, or end of the study period (December 31st 2011). Antidepressant drug dispensing, based on pharmacy records, were subdivided into Tricyclic Antidepressants (TCAs), Selective Serotonin Reuptake Inhibitors (SSRIs) and other antidepressants. One-year prevalence, 5-year incidence and duration of antidepressant use were calculated. RESULTS: Yearly prevalence of antidepressant use increased from 3.9% in 1991 to 8.3% of the population in 2011. The increase in SSRI use was 5.8-fold, whereas use of other antidepressants doubled and TCA use remained stable over time. Incidence of all antidepressants decreased from 23.9 to 14.2 per 1000 person-years between 1992 and 2011. The duration of a first treatment episode increased over time. CONCLUSION: Despite the prevalence of antidepressant use increased over time, incidence did not, which is most likely explained by a longer treatment duration and recurrent episodes.
Authors: Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij Journal: Eur J Epidemiol Date: 2015-09-19 Impact factor: 8.082
Authors: Raymond Noordam; Nikkie Aarts; Katia M Verhamme; Miriam C M Sturkenboom; Bruno H Stricker; Loes E Visser Journal: Eur J Clin Pharmacol Date: 2015-01-06 Impact factor: 2.953
Authors: Nevena M Maljuric; Raymond Noordam; Nikkie Aarts; Maartje N Niemeijer; Marten E van den Berg; Albert Hofman; Jan A Kors; Bruno H Stricker; Loes E Visser Journal: Br J Clin Pharmacol Date: 2015-07-29 Impact factor: 4.335
Authors: Raymond Noordam; Colleen M Sitlani; Christy L Avery; James D Stewart; Stephanie M Gogarten; Kerri L Wiggins; Stella Trompet; Helen R Warren; Fangui Sun; Daniel S Evans; Xiaohui Li; Jin Li; Albert V Smith; Joshua C Bis; Jennifer A Brody; Evan L Busch; Mark J Caulfield; Yii-Der I Chen; Steven R Cummings; L Adrienne Cupples; Qing Duan; Oscar H Franco; Rául Méndez-Giráldez; Tamara B Harris; Susan R Heckbert; Diana van Heemst; Albert Hofman; James S Floyd; Jan A Kors; Lenore J Launer; Yun Li; Ruifang Li-Gao; Leslie A Lange; Henry J Lin; Renée de Mutsert; Melanie D Napier; Christopher Newton-Cheh; Neil Poulter; Alexander P Reiner; Kenneth M Rice; Jeffrey Roach; Carlos J Rodriguez; Frits R Rosendaal; Naveed Sattar; Peter Sever; Amanda A Seyerle; P Eline Slagboom; Elsayed Z Soliman; Nona Sotoodehnia; David J Stott; Til Stürmer; Kent D Taylor; Timothy A Thornton; André G Uitterlinden; Kirk C Wilhelmsen; James G Wilson; Vilmundur Gudnason; J Wouter Jukema; Cathy C Laurie; Yongmei Liu; Dennis O Mook-Kanamori; Patricia B Munroe; Jerome I Rotter; Ramachandran S Vasan; Bruce M Psaty; Bruno H Stricker; Eric A Whitsel Journal: J Med Genet Date: 2016-12-30 Impact factor: 6.318
Authors: Jacoline J van den Driest; Dieuwke Schiphof; Aafke R Koffeman; Marc A Koopmanschap; Patrick J E Bindels; Sita M A Bierma-Zeinstra Journal: Arthritis Rheumatol Date: 2022-03-16 Impact factor: 15.483
Authors: Antony Arthur; George M Savva; Linda E Barnes; Ayda Borjian-Boroojeny; Tom Dening; Carol Jagger; Fiona E Matthews; Louise Robinson; Carol Brayne Journal: Br J Psychiatry Date: 2020-01 Impact factor: 9.319